Endovascular thrombectomy of large ischemic strokes: Reimagining the boundaries of reperfusion.
Ahmad A BalloutPublished in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2023)
The cumulative results of the SELECT-2, ANGEL-ASPECTS, and RESCUE-JAPAN LIMIT clinical trials suggest that endovascular thrombectomy performed within 24 h of symptom onset, in patients presenting with large ischemic strokes, defined by parenchymal and/or perfusion imaging, is safe and is associated with better functional outcomes with a treatment effect that persisted across all subgroups of patients. Our aim was to review these studies and to discuss the implications that these studies may have on patient selection, systems of care, and the utility of our imaging modalities.
Keyphrases
- acute ischemic stroke
- clinical trial
- high resolution
- end stage renal disease
- cerebral ischemia
- newly diagnosed
- case report
- palliative care
- chronic kidney disease
- acute myocardial infarction
- case control
- magnetic resonance imaging
- peritoneal dialysis
- atrial fibrillation
- patient reported outcomes
- mass spectrometry
- blood brain barrier
- aortic dissection
- acute coronary syndrome
- phase ii
- computed tomography
- health insurance
- heart failure